Kai insights — Jan 2026
Vita Embryo rollout updates, AI-in-IVF trends from 2025, and the top questions clinics ask most.
|
|
|
Vita Embryo adoption is in full swing |
|
|
Kai Health has entered an active rollout phase, as Vita Embryo moves from onboarding to routine use across clinics. Early feedback highlights the value of AI in improving consistency and standardization, supporting more aligned decision-making alongside clinicians.
We also share what we’re building next to better fit real clinical needs.
|
|
|
2025 AI IVF trend recap: from scores to workflow standardization
|
|
|
In 2025, the conversation around AI in IVF shifted from “AI scores” to how AI fits into real lab workflows, and what it takes to deploy responsibly. A global survey comparing 2022 vs 2025 perspectives highlights embryo selection as the core use case, while practical barriers (cost, training, and validation) remain key blockers.
We summarized 2 to 3 takeaways and what they imply for 2026.
|
|
|
Top 5 questions clinics ask about Vita Embryo
|
|
|
Clinics usually start with practical questions: how it works, how to interpret the outputs, and how to use them alongside existing grading.
Vita Embryo provides two types of AI outputs: an AI Score for prioritization discussions, and an AI-assisted morphology grading (e.g., Stage/ICM/TE) to support more consistent interpretation within the team.
We answered the top five questions in a simple, clinic-friendly format—plus how teams typically use the report in real workflows. |
|
|
How was this month's Kai insights? |
|
|
Interested? Contact us below and we will be glad to help! |
|
|
|
Personalized Fertility Treatment Powered by AI, Kai Health
#701, 398, Seocho-daero, Seocho-gu, Seoul |
|
|
|
|
